Articles tagged with P38 Pathway
A new study reveals that p38 MAPK plays a key role in epigenetic regulation of fibrotic genes in lung fibroblasts, particularly in senescent cells. Pharmacological inhibition of p38 MAPK significantly reduced α-SMA and Col3A1 expression, suggesting a potential therapeutic target for treating age-related fibrotic diseases like IPF.
Researchers at University of Pittsburgh developed a new treatment approach for anthrax by reactivating the ERK pathway with a combination of growth factors. This method shows promise for treating the disease beyond its typical point of no return, offering hope for patients diagnosed late in the illness.
A team of researchers has discovered a new inactive form of the p38a protein, which is regulated by the cellular redox state. This finding opens up new avenues for developing therapeutic compounds that modulate the activity of p38a more precisely.
The study found that solely the omicron variant influences cell cycle genes, leading to increased p21 expression and a senescence-associated secretory phenotype. This results in premature cellular senescence, potentially contributing to the reported cytokine storm and development of long-COVID.
Researchers at IRB Barcelona have developed new p38 inhibitors that selectively impair one of the activation pathways of the protein, allowing it to perform many of its normal functions. The inhibitors show therapeutic potential for heart diseases such as cardiac cell death and cardiotoxicity.
Researchers at the University of Bonn have identified a new signaling pathway that triggers inflammatory responses in the skin after UV damage. This pathway involves the activation of p38 molecularly modifying NLRP1, a critical switch for inflammation, and initiates the assembly of inflammasomes.
A study by CNIC scientists has identified a key role for the MKK3/6–p38γ/δ signaling pathway in cardiac hypertrophy. Inhibition of p38α promotes an unexpected activation of the other branch of the pathway, consisting of the proteins MKK3, p38γ, and p38δ. This activation induces another key pathway in cardiac hypertrophy, the mTOR pathway.
The study reveals that MK2 protein levels act as a molecular indicator for cell survival or death, with higher levels associated with cell death and lower levels linked to survival. Moderate stress triggers temporary activation of the p38-MK2 pathway, allowing cells to recover.
Researchers discovered a key signaling pathway in adult fly intestines that promotes intestinal regeneration after stress. This finding has potential applications for regenerative medicine, particularly in treating inflammatory bowel diseases and colorectal cancer.
A new study has identified molecules that send detrimental signals in preeclampsia patients, which may lead to poor health outcomes in babies born to mothers with the syndrome. The researchers found that these molecules are associated with increased risk of disease later in life.
Researchers found that activating p38alpha MAPK reduces stress resilience by decreasing serotonin levels in the brain. This leads to depression-like behaviors, social avoidance, and drug-seeking behavior. The study suggests a novel therapeutic target to promote stress resilience.
A study by UCSD researchers shows that the central nervous system can sense and modulate inflammation in joints, reducing symptoms of rheumatoid arthritis. Blocking key signaling enzymes in the CNS resulted in decreased joint inflammation and destruction.